02May 2025
TANGO Regimen: Optimizing Anti-VEGF Treatment for nAMD

TANGO Regimen: Optimizing Anti-VEGF Treatment for nAMD

This report introduces the TANGO regimen—Tailored Anti-VEGF therapy with New Generation Optimizations—for neovascular age-related macular degeneration. TANGO leverages newer, longer-acting anti-VEGF agents to potentially reduce injection frequency and clinic visits. Simulation results suggest TANGO could maintain treatment intensity for high-need patients while minimizing overall burden. Clinical studies are needed to confirm its real-world safety and effectiveness.

  • #ophthalmology

Like

Save

Share